The clinical characteristics, therapy and outcome of 85 adults with acute lymphoblastic leukemia and t(4;11)(q21;q23)/MLL-AFF1 prospectively treated in the UKALLXII/ECOG2993 trial

The biology and outcome of adult t(4;11)(q21;q23)/MLL-AFF1 acute lymphoblastic leukemia are poorly understood. We describe the outcome and delineate prognostic factors and optimal post-remission therapy in 85 consecutive patients (median age 38 years) treated uniformly in the prospective trial UKALL...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Marks, David I., Moorman, Anthony V., Chilton, Lucy, Paietta, Elisabeth, Enshaie, Amir, DeWald, Gordon, Harrison, Christine J., Fielding, Adele K., Foroni, Letizia, Goldstone, Anthony H., Litzow, Mark R., Luger, Selina M., McMillan, Andrew K., Racevskis, Janis, Rowe, Jacob M., Tallman, Martin S., Wiernik, Peter, Lazarus, Hillard M.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Ferrata Storti Foundation 2013
Konular:
Original Articles and Brief Reports
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3669452/
https://ncbi.nlm.nih.gov/pubmed/23349309
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2012.081877
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller